AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here's What Could Drive ATRC Stock Next
AtriCure, Inc.
Atricure Inc. (ATRC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hood River Capital Management David Swank | 2,905,299 | $81,290,266 | -7% | 0.59% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,333,904 | $37,322,635 | -10% | 0.03% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,296,209 | $36,267,928 | +367% | 0.02% |
| 4. | Divisadero Street Capital William Zolezzi | 800,931 | $22,410,049 | -31% | 0.51% |
| 5. | Point72 Asset Management Steve Cohen | 604,380 | $16,910,552 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.25 | 5,000 | $111,250.00 | 103,290 | 2024-05-30 | Filing | |
| $76.68 | 34 | $2,607.12 | 16,228 | 2021-04-30 | Filing | |
| $40.54 | 12,350 | $500,669.00 | 41,036 | 2020-11-17 | Filing | |
| $24.86 | 500 | $12,430.00 | 25,670 | 2019-09-12 | Filing | |
| $17.64 | 11,000 | $194,040.00 | 16,805 | 2018-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.00 | 4,519 | $271,140.00 | 142,745 | 2026-09-23 | Filing | |
| $54.22 | 5,313 | $288,070.86 | 34,546 | 2026-09-11 | Filing | |
| $55.00 | 3,657 | $201,135.00 | 147,264 | 2026-09-08 | Filing | |
| $52.50 | 7,763 | $407,557.50 | 150,921 | 2026-09-02 | Filing | |
| $48.89 | 9,370 | $458,099.30 | 87,319 | 2026-08-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 89 | $5,002 | 0% |
News See All
Beyond Consensus: Earnings Surprises That Shook Wall Street Yesterday
As over 150 companies released their second-quarter earnings on July 23, investors were still absorbing the headline economic event of the day as the US Trade Representative announced new 10% to 12.5% ...
Top 10 Small Cap Stocks With Huge Growth Potential
In this article, we will discuss the Top 10 Small Cap Stocks With Huge Growth Potential.
AtriCure, Inc. (NASDAQ:ATRC) Q1 2026 Earnings Call Transcript
AtriCure, Inc. (NASDAQ:ATRC) Q1 2026 Earnings Call Transcript May 6, 2026 Operator: Good afternoon, and welcome to AtriCure's First Quarter 2026 Earnings Conference Call.
AtriCure (ATRC) Slid Despite Strong Earnings
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q1 2026 investor letter. A copy of the letter can be downloaded here.
AtriCure, Inc. (NASDAQ:ATRC) Q4 2025 Earnings Call Transcript
AtriCure, Inc. (NASDAQ:ATRC) Q4 2025 Earnings Call Transcript February 17, 2026AtriCure, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.04.
Analysts See an Over 26% Upside in AtriCure (ATRC)
AtriCure (NASDAQ:ATRC) is one of the most promising mid-cap healthcare stocks under $50. On December 16, J.P. Morgan analyst Lilia-Celine (Lily) reiterated her bullish stance on AtriCure (NASDAQ:ATRC).
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
AtriCure, Inc. (NASDAQ:ATRC) Q3 2025 Earnings Call Transcript
AtriCure, Inc. (NASDAQ:ATRC) Q3 2025 Earnings Call Transcript October 29, 2025AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.11.
Do You Believe in the Upside Potential of Atricure (ATRC)?
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center